Neurology 1006 - Neurology Alert - Jun 01, 2006

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Fred Plum, MD
University Professor;
Department of Neurology;
Cornell University Medical College

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology
Cornell University Medical College
New York, NY

Editor
Matthew E. Fink, MD
Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Assistant Editors
John J. Caronna, MD
Vice-Chairman
Department of Neurology
Cornell University Medical Center;
Professor of Clinical Neurology
New York Presbyterian Hospital

Claire Henchcliffe, MD, DPhil
Assistant Professor
Department of Neurology
Weill Medical College
Cornell University

Charles Pollak, MD
Professor
Clinical Neurology
Director
Center for Sleep Disorder

Dara Jamieson, MD
Associate Professor
Clinical Neurology Director
Headache Center

Michael Rubin, MD
Professor of Clinical Neurology
New York Presbyterian Hospital
Cornell Campus

Author
Norman Latov, MD, PhD
Professor of Neurology and Neuroscience
Director
Peripheral Neuropathy Center
Weill Medical College of Cornell University

Subjects:

  • Rivastigmine: Sustained Benefits for Parkinson's Disease Dementia
  • A Genetic Cause for Primary Intracerebral Hemorrhage?
  • Sleep—Sometimes a Test of Survival
  • Carotid Artery Stenting and Endarterectomy Compared
  • Evaluation of Neuropathy in Diabetes
  • Migraine: More Than Just a Headache!
  • Electrodiagnostic Study of Anorectal Dysfunction

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present "basic science? lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Fred Plum, MD, reports no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company having ties to this field of study. Editor Matthew E. Fink, MD and assistant editor John J. Caronna, MD report no financial relationship relevant to this field of study. Assistant editor Claire Henchcliffe, MD, DPhil is on the speaker's bureau for GlaxoSmithKline, Teva/Eisai, and Boehringer Ingelheim. Assistant editor Charles Pollak, MD is a stockholder for Merck, and is on the speaker's bureau for Merck. Author Norman Latov, MD, PhD is a consultant for Quest Diagnostics and Talecris Biotherapeutics, Inc., is a stockholder for Therapath LLC, and has royalties in Athena Diagnostics. Assistant editor Dara Jamieson, MD is a consultant for Boehringer Ingelheim and Merck, and is on the speaker’s bureau for Boehringer Ingelheim, Merck, Ortho-McNeil, and Pfizer. Assistant editor Michael Rubin, MD is on the speaker’s bureau for Athena Diagnostics, and does research for Pfizer and Merck.

Copyright 2006 AHC Media. All rights reserved.